Clostridial translocation peptides for promoting endosomal escape of RNAi agents (WO09083738)

Bibliography

• Sahu NK, Shilakari G, Nayak A, Kohli DV. Antisense technology: a selective tool for gene expression regulation and gene targeting. Curr Pharm Biotechnol 2007;8:291-304
   Google Scholar
• Ahktar S, Benter I. Non-viral delivery of synthetic siRNAs in vivo. J Clin Invest 2007;117:3623-32
   Google Scholar
• Grimm D, Kay MA. RNAi and gene therapy: a mutual attraction. Hematology Am Soc Hematol Educ Program 2007;473-81
   Google Scholar
• Fire A, Xu S, Montgomery M, Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-11
   PubMed Web of Science ®Google Scholar
• van den Berg A, Mols J, Han J. RISC-target interaction: cleavage and translational suppression. Biochim Biophys Acta 2008;1779:668-77
   PubMed Web of Science ®Google Scholar
• Rayburn ER, Zhang R. Antisense, RNAi, and gene silencing strategies for therapy: mission or mission impossible? Drug Discov Today 2008;13:513-21
   PubMed Web of Science ®Google Scholar
• Urban-Klein B, Werth S, Abuharbeid S, RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther 2005;12:461-6
   PubMed Web of Science ®Google Scholar
• Bartlett DW, Su H, Hildebrandt IJ, Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci USA 2007;104:15549-54
   PubMed Web of Science ®Google Scholar
• Davis ME, Zuckerman JE, Choi CH, Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010;464(7291):1067-70
   PubMed Web of Science ®Google Scholar
• Zimmermann TS, Lee ACH, Akinc A, RNAi-mediated gene silencing in non-human primates. Nature 2006;441:111-4
   PubMed Web of Science ®Google Scholar
• Semple SC, Akinc A, Chen J, Rational design of cationic lipids for siRNA delivery. Nat Biotechnol 2010;28:172-6
   PubMed Web of Science ®Google Scholar
• Sato Y, Murase K, Kato J, Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol 2008;26:431-42
   PubMed Web of Science ®Google Scholar
• Frank-Kamenetsky M, Grefhorst A, Anderson NN, Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc Natl Acad Sci USA 2008;105:11915-20
   PubMed Web of Science ®Google Scholar
• Love KT, Mahon KP, Levins CG, Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci USA 2010;107:1864-9
   PubMed Web of Science ®Google Scholar
• Kumar P, Wu H, McBride JL, Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007;448:39-43
   PubMed Web of Science ®Google Scholar
• Bareford LM, Swaan PW. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 2007;59:748-58
   PubMed Web of Science ®Google Scholar
• Vivés E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 1997;272:16010-17
   PubMed Web of Science ®Google Scholar
• Rummel A, Mahrhold S, Bigalke H, Binz T. The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction. Mol Microbiol 2004;51:631-43
   PubMed Web of Science ®Google Scholar
• Rummel A, Eichner T, Weil T, Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Proc Natl Acad Sci USA 2007;104:359-64
   PubMed Web of Science ®Google Scholar
• Black JD, Dolly JO. Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves. J Cell Biol 1986;103:521-34
   PubMed Web of Science ®Google Scholar
• Black JD, Dolly JO. Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis. J Cell Biol 1986;103:535-44
   PubMed Web of Science ®Google Scholar
• Montecucco C, Papini E, Schiavo G. Bacterial protein toxins enter cells via a four-step mechanism. FEBS Lett 1994;346:92-8
   PubMed Web of Science ®Google Scholar
• Mäe M, El Andaloussi S, Lundin P, A stearylated CPP for the delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy. J Control Release 2009;134:221-7
   PubMed Web of Science ®Google Scholar
• Wickner W, Schekman R. Membrane fusion. Nat Struct Mol Biol 2008;15:658-64
   Google Scholar
• Tönges L, Lingor P, Egle R, Stearylated octaarginine and artificial virus-like particles for transfection of siRNA into primary rat neurons. RNA 2006;12:1431-8
   PubMed Web of Science ®Google Scholar
• Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 2004;10:310-5
   PubMed Web of Science ®Google Scholar
• Akinc A, Thomas M, Klibanov AM, Langer R. Exploring polyetyleneimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 2005;7:657-63
   PubMed Web of Science ®Google Scholar
• Braasch DA, Paroo Z, Constantinescu A, Biodistribution of phosphodiester and phosphorothioate siRNA. Bioorg Med Chem Lett 2004;14:1139-43
   PubMed Web of Science ®Google Scholar
• Crombez L, Morris MC, Dufort S, Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumor growth. Nucleic Acids Res 2009;37:4559-69
   PubMed Web of Science ®Google Scholar
• Lundberg P, El Andaloussi S, Sütlü T, Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J 2007;21:2664-71
   PubMed Web of Science ®Google Scholar
• Merkel OM, Beyerle A, Librizzi D, Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance. Mol Pharm 2009;6:1246-60
   PubMed Web of Science ®Google Scholar
• Schiffelers RM, Ansari A, Xu J, Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res 2004;32:e149
   PubMed Web of Science ®Google Scholar